About Molecular Theranostics
Molecular Theranostics is a company based in Cleveland (United States) founded in 2014.. Molecular Theranostics offers products and services including MT218 and MTP220. Molecular Theranostics operates in a competitive market with competitors including Scholar Rock, SamanTree Medical, Lightpoint Medical, Ionpath and Fluxion Biosciences, among others.
- Headquarter Cleveland, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Molecular Theranostics, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$294.51 K (USD), Grant
Jul 17, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecular Theranostics
Molecular Theranostics offers a comprehensive portfolio of products and services, including MT218 and MTP220. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables early detection and risk-stratification of aggressive cancers.
Facilitates non-invasive assessment of cancer therapy efficacy.
Funding Insights of Molecular Theranostics
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $294,505
-
First Round
First Round
(21 Jul 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Grant - Molecular Theranostics | Valuation |
investors |
|
| Aug, 2023 | Amount | Grant - Molecular Theranostics | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - Molecular Theranostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molecular Theranostics
Molecular Theranostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molecular Theranostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Molecular Theranostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molecular Theranostics Comparisons
Competitors of Molecular Theranostics
Molecular Theranostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scholar Rock, SamanTree Medical, Lightpoint Medical, Ionpath and Fluxion Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| domain | founded_year | HQ Location |
A surgical digital microscope for tumor resection is developed.
|
|
| domain | founded_year | HQ Location |
Intraoperative imaging devices for real-time cancer detection are developed.
|
|
| domain | founded_year | HQ Location |
Multiplexed ion beam imaging platform for tissue biopsies is developed.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based tools for cellular analysis are provided.
|
|
| domain | founded_year | HQ Location |
Provider of virtual lens that generates High definition images without high-quality lenses
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Molecular Theranostics
When was Molecular Theranostics founded?
Molecular Theranostics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Molecular Theranostics located?
Molecular Theranostics is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.
Who is the current CEO of Molecular Theranostics?
Yajuan Li is the current CEO of Molecular Theranostics.
What does Molecular Theranostics do?
Molecular Theranostics was founded in 2014 in Cleveland, United States, with operations centered on biotechnology for cancer diagnostics. Non-invasive imaging technologies are developed to enable early detection and characterization of aggressive tumors. Key products include MT218, a small peptide-targeted MRI contrast agent, and MTP219, a PET probe. These tools are designed for precise tumor imaging in clinical settings.
Who are the top competitors of Molecular Theranostics?
Molecular Theranostics's top competitors include Scholar Rock, Ionpath and SamanTree Medical.
What products or services does Molecular Theranostics offer?
Molecular Theranostics offers MT218 and MTP220.
Who are Molecular Theranostics's investors?
Molecular Theranostics has 1 investor. Key investors include HHS.